{"id":564683,"date":"2026-03-26T02:34:24","date_gmt":"2026-03-26T02:34:24","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/564683\/"},"modified":"2026-03-26T02:34:24","modified_gmt":"2026-03-26T02:34:24","slug":"is-eli-lilly-lly-the-best-healthcare-stock-to-buy-according-to-jim-cramer","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/564683\/","title":{"rendered":"Is Eli Lilly (LLY) The Best Healthcare Stock to Buy According to Jim Cramer?"},"content":{"rendered":"\n<p class=\"yf-1fy9kyt\">We just covered the <a href=\"https:\/\/www.insidermonkey.com\/blog\/jim-cramer-stock-portfolio-top-10-stock-picks-1722623\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Jim Cramer Stock Portfolio: Top 10 Stock Picks;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Jim Cramer Stock Portfolio&quot;}\" class=\"link \">Jim Cramer Stock Portfolio: Top 10 Stock Picks<\/a>. Eli Lilly and Company (NYSE:LLY) ranks #9 (see the <a href=\"https:\/\/www.insidermonkey.com\/blog\/jim-cramer-stock-portfolio-top-5-stock-picks-1722622\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Jim Cramer\u2019s top 5 stock picks in 2026 here;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Jim Cramer\u2019s top 5 stock picks in 2026 here&quot;}\" class=\"link \">Jim Cramer\u2019s top 5 stock picks in 2026 here<\/a>).<\/p>\n<p class=\"yf-1fy9kyt\">Jim Cramer has long been a believer in Eli Lilly and Company (NYSE:LLY). In November, he said on CNBC that the company is likely to hit the $1 trillion market cap milestone amid its weight-loss pill catalyst. LLY is a key part of Jim Cramer stock portfolio for 2026.<\/p>\n<p class=\"yf-1fy9kyt\">Eli Lilly and Company (NYSE:LLY) is preparing to launch its new oral obesity drug, orforglipron, in the United \u200bStates as early as the second quarter of \u200bthis year, subject to FDA approval, according to a Reuters report.<\/p>\n<p class=\"yf-2nfcqq\">\u201cThis pill that they have, GLP-1, the idea that you\u2019ll just be able to get it for weight loss, not comorbidity. People are beginning to realize maybe this thing is worth far more,\u201d Cramer said in November. \u201cEli Lilly is a great company. Dave Ricks (CEO), by the way, the company does a lot of work. Dave Ricks is a really unbelievable man. But what he\u2019s really driving is a company that\u2019s going to pass $1 trillion. Congratulations to him.\u201d<\/p>\n<p class=\"yf-1fy9kyt\">Jensen Quality Growth Equity Strategy explained in their Q4 letter why LLY rose in Q4 and important points about its incretin portfolio and prospects for expanded Medicare coverage. <a href=\"https:\/\/www.insidermonkey.com\/blog\/eli-lilly-lly-edged-higher-as-multiple-tailwinds-aligned-1710360\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Read the letter in detail here.;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Read the letter in detail here.&quot;}\" class=\"link \">Read the letter in detail here.<\/a><\/p>\n<p>    <img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/03\/a819ba24b68433b00160773d71e89e74.jpeg\" alt=\"\" loading=\"eager\" height=\"492\" width=\"768\" class=\"yf-lglytj  loaded\"\/>     <\/p>\n<p class=\"yf-1fy9kyt\">Pixabay\/Public domain<\/p>\n<p class=\"yf-1fy9kyt\">While we acknowledge the potential of LLY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you&#8217;re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the<a class=\"link \" href=\"https:\/\/www.insidermonkey.com\/blog\/three-megatrends-one-overlooked-stock-massive-upside-1548959\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:\u00a0best short-term AI stock;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;&amp;nbsp&quot;}\">\u00a0best short-term AI stock<\/a>.<\/p>\n<p class=\"yf-1fy9kyt\">READ NEXT:\u00a0<a class=\"link \" href=\"https:\/\/www.insidermonkey.com\/blog\/33-stocks-that-should-double-in-3-years-1709437\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:33 Stocks That Should Double in 3 Years;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;33 Stocks That Should Double in 3 Years&quot;}\">33 Stocks That Should Double in 3 Years<\/a> and <a class=\"link \" href=\"https:\/\/www.insidermonkey.com\/blog\/wp-admin\/post.php?post=1716175&amp;action=edit\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Cathie Wood 2026 Portfolio&quot;}\">Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy<\/a>.\u00a0<\/p>\n<p class=\"yf-1fy9kyt\">Disclosure: None. <a class=\"link \" href=\"https:\/\/news.google.com\/publications\/CAAqLQgKIidDQklTRndnTWFoTUtFV2x1YzJsa1pYSnRiMjVyWlhrdVkyOXRLQUFQAQ?hl=en-US&amp;gl=US&amp;ceid=US%3Aen\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Follow Insider Monkey on Google News;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Follow Insider Monkey on Google News&quot;}\">Follow Insider Monkey on Google News<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"We just covered the Jim Cramer Stock Portfolio: Top 10 Stock Picks. Eli Lilly and Company (NYSE:LLY) ranks&hellip;\n","protected":false},"author":2,"featured_media":564684,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[64,63,146855,92143,137,500,4851,6711],"class_list":["post-564683","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-au","tag-australia","tag-dave-ricks","tag-eli-lilly-and-company","tag-health","tag-healthcare","tag-jim-cramer","tag-stock-picks"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/564683","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=564683"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/564683\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/564684"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=564683"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=564683"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=564683"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}